RUNX1/RUNX1T1 Fusion Probe

RUNX1/RUNX1T1 Fusion Probe

Product Description: acute myeloid leukemia/AML(Non APL)
Applications: hematological tumor

Send InquiryChat Now
Product Details

image.png

RUNX1/RUNX1T1 Fusion Probe

图片1image
          1 hrs hybridization(AML1/ETO)                 16 hrs hybridization(AML1/ETO) 


Product Advantages

1.Fleetness:Tissue probe hybridization time: 2 hours. Cell probe hybridization time: 1 hour. 

2.Accuracy:Less non-specific background staining (dyeing). Increase difficult samples detection rate. 

3.Reproducibility:Different laboratories test results are highly reproducible.


 

◆Probe Description

image002.gif

The ETO probe was labeled with orange-red dye, and the AML1 probe was labeled with green dye, and the two probes were combined to the target detection site by in situ hybridization. 

 

◆Clinical Significance

The AML1/ETO gene fusion can be used as a secondary diagnosis of AML and a means of assessing prognosis. Clinically, t(8;21) leukemia represents a type of acute leukemia with good prognosis. Adult patients have good response to treatment, high complete remission rate, long median survival time, but easy recurrence; children's treatment and prognosis are not as good as adult patients. .


 

◆Size Specification

image006.jpg

Hot Tags: RUNX1/RUNX1T1 fusion probe, suppliers, manufacturers, customized, discount, IVD, free sample, for laboratories, for hospitals, for research center, rapid diagnosis
Related Products
Inquiry